secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0000950170-23-027988
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals stockholders elect three Class II directors, ratify E&Y as auditor
--------------------------------------------------------------------------------

- David Fellows, Jill Quigley, and Radhika Tripuraneni elected as Class II directors with 39.5M, 40.1M, and 45.9M votes for, respectively.
- Ratification of Ernst & Young as independent auditor for FY 2023 passed with 53.4M votes for, 1,549 against, 331 abstentions.
- All director nominees received more votes for than withheld; broker non-votes of 7.4M shares on director election.
- No other business items were presented; all proposals were approved as described in the April 28 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023027988/0000950170-23-027988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023027988/tern-20230612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer